CNS Pharmaceuticals

CNSP

Capitalización de mercado USD 7.09 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Ikarian Capital Dallas, Texas	USD 649 k	+USD 378 k	+90,000	+196%
2	2 ADAR1 Capital Management Austin, Texas	USD 335 k	+USD 294 k	+70,000	Nuevas
3	SCM 3 Stonepine Capital Management Bend, Oregon	USD 199 k	-USD 81.6 k	-19,427	-32%
4	4 Boothbay Fund Management New York	USD 64.6 k	–	–	–
5	5 Vanguard Fiduciary Trust Malvern, Pennsylvania	USD 48.9 k	+USD 42.9 k	+10,226	Nuevas
6	6 Vanguard Capital Management Malvern, Pennsylvania	USD 33.4 k	+USD 29.4 k	+6,993	Nuevas
7	7 UBS Group Zurich, Switzerland	USD 6.98 k	+USD 3.07 k	+732	+100%
8	8 Tower Research Capital (TRC) New York	USD 3.82 k	-USD 2.15 k	-511	-39%
9	9 Barclays London, United Kingdom	USD 91	+USD 80	+19	Nuevas
10	BC 10 Barrett & Company Providence, Rhode Island	USD 38	–	–	–
11	11 Danske Bank Copenhagen K, Denmark	USD 5	–	–	–
12	12 Geode Capital Management Boston, Massachusetts	–	-USD 55.7 k	-23,189	Cerradas
13	13 Sound Income Strategies Ft Lauderdale, Florida	–	-USD 36	-16	Cerradas
14	14 MAI Capital Management Independence, Ohio	–	-USD 8	-3	Cerradas
15	15 Caitong International Asset Management Hong Kong	–	-USD 2	-1	Cerradas
16	16 Citigroup New York	–	-USD 2	-1	Cerradas